Developer docs
API playgroundTry for free, no card

Search company profiles

ACT Laboratories

Full company profile

uuid002dw5v

Namestring
ACT Laboratories
Legal namestring
ACT Laboratories, Inc.
Company typeenum
Private
Founded yearint
2011
Descriptiontext

ACT Laboratories, Inc., founded in 2011 and headquartered in Morton, United States, is a privately held cannabis testing laboratory network serving licensed cannabis operators. The company's offering is analytical laboratory testing across the core cannabis compliance panels — potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination analysis — delivered to cultivators, manufacturers, processors, and dispensaries that require third-party verification to meet state-mandated regulatory requirements. Its underlying technology is conventional analytical instrumentation deployed across a multi-state laboratory footprint rather than a software or AI-driven platform; pricing is per-test on a contract or transactional basis with no publicly disclosed schedule.

The business operates a B2B, enterprise field-sales motion, supplying testing services directly to licensed cannabis businesses through laboratory service agreements rather than through retail or self-service channels. Prior to September 2022, ACT Labs held an undisclosed number of state operations; on 2022-09-28 the company announced the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, bringing the operational footprint to six U.S. states and explicitly signaling intent to enter additional markets by early 2023. The deal was subject to Massachusetts regulatory approval, underscoring the licensing-driven gating of expansion in the cannabis testing vertical.

Revenue mechanics are transaction-fee based, with each compliance test representing a unit of revenue from licensed operators who have no alternative to third-party testing in regulated markets. Headcount is reported in the 11–50 band and the company provides no public revenue, funding, or valuation disclosures. Leadership consists of CEO Cornelius Merlini and Founder/EVP Jeff Nemeth. The U.S. cannabis testing market is projected to reach $8.72 billion by 2030 at a 19.6% CAGR, positioning ACT Laboratories as a roll-up-oriented participant in a fragmented, regulated, and growing vertical.

Short descriptiontext

ACT Laboratories, Inc. is a US-based cannabis testing laboratory network providing analytical testing—potency, pesticide, terpene, residual solvent, and microbial analysis—to licensed cannabis cultivators, manufacturers, and dispensaries across six states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLansing, United States
HQ citystring
Lansing
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis testing services, analytical laboratory testing, potency analysis services, regulatory compliance testing, microbial contamination testing
Industry3 codes
PRIMARYHLAJAIAM
Laboratory Quality Systems, Accreditation & Proficiency Testing Programs
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYAFALAAAK
Proficiency Testing, Method Validation & Reference Materials (Food Labs)
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)
SECONDARYBPACALAE
Drug & Alcohol Testing Coordination
Business & Public Services/HR, Staffing & Recruitment Services/Background Screening & Pre-Employment Verification
NAICS code2 codes
  • Testing Laboratories and Services54138
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Medical Laboratories8071
Product category
Cannabis Testing Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cannabis Testing Services
TypeTransaction Fee
Description

ACT Laboratories generates revenue through providing cannabis testing laboratory services to licensed cannabis cultivators, manufacturers, and dispensaries. Services include safety testing, potency analysis, and regulatory compliance verification across legal cannabis markets.

biospace.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ACT Laboratories provides analytical cannabis testing laboratory services to licensed cannabis operators, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing. Services are delivered from licensed laboratory facilities across six U.S. states to support state regulatory compliance and product safety verification for cannabis cultivators, manufacturers, processors, and dispensaries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Expanded testing capacity and regulatory compliance across six states through CDX Analytics acquisition
Product overview1 text field

ACT Laboratories operates as a cannabis testing laboratory network providing analytical testing services for the cannabis industry. The company's service offering centers on comprehensive cannabis testing, including potency, terpene, pesticide, and microbial analysis, conducted to ensure regulatory compliance for licensed cannabis businesses. The company expanded its geographic footprint through the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, extending operations to six states.

Product and service1 record
1Cannabis Testing Services
CategoryCannabis Testing Services
Description

Comprehensive analytical cannabis testing services for licensed cannabis cultivators, manufacturers, processors, and dispensaries, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing delivered across six U.S. states for regulatory compliance and product safety verification.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-28
Description

ACT Laboratories acquired CDX Analytics, a Massachusetts-based cannabis testing laboratory, as part of its geographic expansion strategy. The acquisition enhanced ACT's operational footprint to six states and expanded testing capacity and regulatory compliance capabilities. The deal was subject to regulatory approval in Massachusetts.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

SGS is a global testing, inspection, and certification company with agricultural and food testing capabilities — overlapping analytical methods and quality system expertise relevant to cannabis testing.

TypeDirect peer
Description

CW Analytical is a California-based cannabis testing laboratory offering comparable compliance testing services to licensed cannabis operators.

TypeDirect peer
Description

SC Labs is a multi-state cannabis testing laboratory offering a similar full-panel compliance testing menu to licensed operators, with overlapping geographic presence in Western US states.

TypeDirect peer
Description

Steep Hill is a multi-state cannabis testing and analytics company with overlapping service offerings (potency, terpene, contaminant testing) and licensed-operator customer base.

TypeDirect peer
Description

MCR Labs is a Massachusetts-based cannabis testing laboratory with comparable service offerings to ACT's CDX Analytics subsidiary and overlapping customer base in the Northeast.

TypeDirect peer
Description

ACS Laboratory is a multi-state cannabis testing lab offering full-panel compliance testing (potency, terpenes, pesticides, microbials, residual solvents) to licensed operators — directly comparable to ACT Labs.

TypeBroad incumbent
Description

Eurofins is a global testing services conglomerate with broad analytical testing capabilities including food, environmental, and pharmaceutical testing — comparable analytical methods and regulatory expertise at much larger scale.

TypeDirect peer
Description

Anresco is an ISO-accredited cannabis and food testing laboratory providing potency, contaminant, and regulatory testing services — comparable analytical methods and customer base.

TypeDirect peer
Description

CannaSafe is a California-based cannabis testing laboratory offering potency, pesticide, residual solvent, and microbial testing — directly comparable service portfolio and customer base to ACT Labs.

10PSI (Pharmacology & Toxicology Services)
TypeDirect peer
Description

PSI is a cannabis testing laboratory offering potency and contaminant testing to licensed operators, comparable in scope and customer segment to ACT Labs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ACT Laboratories

Cannabis Testing Servicesactlaboratoriesinc.com

ACT Laboratories, Inc. is a US-based cannabis testing laboratory network providing analytical testing—potency, pesticide, terpene, residual solvent, and microbial analysis—to licensed cannabis cultivators, manufacturers, and dispensaries across six states.

What ACT Laboratories does

ACT Laboratories, Inc., founded in 2011 and headquartered in Morton, United States, is a privately held cannabis testing laboratory network serving licensed cannabis operators. The company's offering is analytical laboratory testing across the core cannabis compliance panels — potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination analysis — delivered to cultivators, manufacturers, processors, and dispensaries that require third-party verification to meet state-mandated regulatory requirements. Its underlying technology is conventional analytical instrumentation deployed across a multi-state laboratory footprint rather than a software or AI-driven platform; pricing is per-test on a contract or transactional basis with no publicly disclosed schedule.

The business operates a B2B, enterprise field-sales motion, supplying testing services directly to licensed cannabis businesses through laboratory service agreements rather than through retail or self-service channels. Prior to September 2022, ACT Labs held an undisclosed number of state operations; on 2022-09-28 the company announced the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, bringing the operational footprint to six U.S. states and explicitly signaling intent to enter additional markets by early 2023. The deal was subject to Massachusetts regulatory approval, underscoring the licensing-driven gating of expansion in the cannabis testing vertical.

Revenue mechanics are transaction-fee based, with each compliance test representing a unit of revenue from licensed operators who have no alternative to third-party testing in regulated markets. Headcount is reported in the 11–50 band and the company provides no public revenue, funding, or valuation disclosures. Leadership consists of CEO Cornelius Merlini and Founder/EVP Jeff Nemeth. The U.S. cannabis testing market is projected to reach $8.72 billion by 2030 at a 19.6% CAGR, positioning ACT Laboratories as a roll-up-oriented participant in a fragmented, regulated, and growing vertical.

ACT Laboratories firmographics

Firmographics
Name
ACT Laboratories
Legal name
ACT Laboratories, Inc.
Website
https://actlaboratoriesinc.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
ACT Laboratories, Inc. is a US-based cannabis testing laboratory network providing analytical testing—potency, pesticide, terpene, residual solvent, and microbial analysis—to licensed cannabis cultivators, manufacturers, and dispensaries across six states.
Ownership category
akta.pro rank

ACT Laboratories industry classification

Industry
Product category
Cannabis Testing Services
NAICS
Testing Laboratories and Services (54138), Medical and Diagnostic Laboratories (6215)
SIC
Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAJAIAM
Laboratory Quality Systems, Accreditation & Proficiency Testing Programs
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYAFALAAAK
Proficiency Testing, Method Validation & Reference Materials (Food Labs)
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)
SECONDARYBPACALAE
Drug & Alcohol Testing Coordination
Business & Public Services/HR, Staffing & Recruitment Services/Background Screening & Pre-Employment Verification

Keywords

  • Cannabis testing services
  • Analytical laboratory testing
  • Potency analysis services
  • Regulatory compliance testing
  • Microbial contamination testing

Where ACT Laboratories is headquartered

Location

Headquarters

HQ city
Lansing
HQ country
United States
HQ region
North America

Markets served

ACT Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Cannabis Testing Services: ACT Laboratories generates revenue through providing cannabis testing laboratory services to licensed cannabis cultivators, manufacturers, and dispensaries. Services include safety testing, potency analysis, and regulatory compliance verification across legal cannabis markets.

Go-to-market motion1 record

Distribution channels1 record

ACT Laboratories product offering

Product offering

Core offering

ACT Laboratories provides analytical cannabis testing laboratory services to licensed cannabis operators, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing. Services are delivered from licensed laboratory facilities across six U.S. states to support state regulatory compliance and product safety verification for cannabis cultivators, manufacturers, processors, and dispensaries.

Product overview

ACT Laboratories operates as a cannabis testing laboratory network providing analytical testing services for the cannabis industry. The company's service offering centers on comprehensive cannabis testing, including potency, terpene, pesticide, and microbial analysis, conducted to ensure regulatory compliance for licensed cannabis businesses. The company expanded its geographic footprint through the acquisition of CDX Analytics, a Massachusetts-based cannabis testing laboratory, extending operations to six states.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cannabis Testing Services Comprehensive analytical cannabis testing services for licensed cannabis cultivators, manufacturers, processors, and dispensaries, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing delivered across six U.S. states for regulatory compliance and product safety verification.

Quantifiable outcome

  • Expanded testing capacity and regulatory compliance across six states through CDX Analytics acquisition

Companies that use ACT Laboratories

Customer profile

Segments1 record

Ideal customer profiles1 record

ACT Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ACT Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CDX AnalyticscoreStrategic or Co-development Partner · 28 September 2022ACT Laboratories acquired CDX Analytics, a Massachusetts-based cannabis testing laboratory, as part of its geographic expansion strategy. The acquisition enhanced ACT's operational footprint to six states and expanded testing capacity and regulatory compliance capabilities. The deal was subject to regulatory approval in Massachusetts.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

ACT Laboratories competitors and assessment

Company assessment

Broad incumbents

  • SGS: SGS is a global testing, inspection, and certification company with agricultural and food testing capabilities — overlapping analytical methods and quality system expertise relevant to cannabis testing.
  • Eurofins Scientific: Eurofins is a global testing services conglomerate with broad analytical testing capabilities including food, environmental, and pharmaceutical testing — comparable analytical methods and regulatory expertise at much larger scale.

Direct peers

  • CW Analytical: CW Analytical is a California-based cannabis testing laboratory offering comparable compliance testing services to licensed cannabis operators.
  • SC Labs: SC Labs is a multi-state cannabis testing laboratory offering a similar full-panel compliance testing menu to licensed operators, with overlapping geographic presence in Western US states.
  • Steep Hill: Steep Hill is a multi-state cannabis testing and analytics company with overlapping service offerings (potency, terpene, contaminant testing) and licensed-operator customer base.
  • MCR Labs: MCR Labs is a Massachusetts-based cannabis testing laboratory with comparable service offerings to ACT's CDX Analytics subsidiary and overlapping customer base in the Northeast.
  • ACS Laboratory: ACS Laboratory is a multi-state cannabis testing lab offering full-panel compliance testing (potency, terpenes, pesticides, microbials, residual solvents) to licensed operators — directly comparable to ACT Labs.
  • Anresco Laboratories: Anresco is an ISO-accredited cannabis and food testing laboratory providing potency, contaminant, and regulatory testing services — comparable analytical methods and customer base.
  • CannaSafe: CannaSafe is a California-based cannabis testing laboratory offering potency, pesticide, residual solvent, and microbial testing — directly comparable service portfolio and customer base to ACT Labs.
  • PSI (Pharmacology & Toxicology Services): PSI is a cannabis testing laboratory offering potency and contaminant testing to licensed operators, comparable in scope and customer segment to ACT Labs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

ACT Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ACT Laboratories leadership team

Management profile

Number of profiles

Profiles2 records

ACT Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ACT Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ACT Laboratories M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACT Laboratories

What does ACT Laboratories do?

ACT Laboratories provides analytical cannabis testing laboratory services to licensed cannabis operators, including potency analysis, terpene profiling, pesticide screening, residual solvent testing, and microbial contamination testing. Services are delivered from licensed laboratory facilities across six U.S. states to support state regulatory compliance and product safety verification for cannabis cultivators, manufacturers, processors, and dispensaries.

Is ACT Laboratories a public or private company?

ACT Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ACT Laboratories founded?

ACT Laboratories was founded in 2011. It employs 101 to 250 people.

Where is ACT Laboratories based?

ACT Laboratories is headquartered in Lansing, United States, in the North America region.

How does ACT Laboratories make money?

One revenue line is on record: cannabis Testing Services.

Who are ACT Laboratories's main competitors?

Broad incumbents on record are SGS and Eurofins Scientific. Direct peers are CW Analytical, SC Labs, Steep Hill, MCR Labs, ACS Laboratory, Anresco Laboratories, CannaSafe and PSI (Pharmacology & Toxicology Services).

Does ACT Laboratories have an API?

No public API is recorded for ACT Laboratories.

What industry is ACT Laboratories in?

ACT Laboratories's product category is Cannabis Testing Services. Its primary akta.pro industry code is HLAJAIAM, Laboratory Quality Systems, Accreditation & Proficiency Testing Programs, with a secondary code of AFALAAAK, Proficiency Testing, Method Validation & Reference Materials (Food Labs). Its NAICS code is 54138 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageACT LAB Expands National Laboratory Network To New JerseyACT LAB expanded its laboratory network into New Jersey by acquiring Sriven Labs, enhancing its testing and compliance services for the state's regulated cannabis market. This move leverages the company's expertise and infrastructure to support local operators and strengthen confidence in cannabis products.ActlabSriven Labs (SV Labs – NJ) Is Now ACT LAB: Here’s What To ExpectSriven Labs has rebranded as ACT LAB and expanded its testing network to New Jersey. The company offers fully licensed and accredited cannabis testing, plant pathogen testing, and environmental monitoring. It provides a client portal for 24/7 access to test results and COAs.PR NewswireACT Laboratories, Inc. Extends Multi-State Expansion Strategy into FloridaACT Laboratories, Inc. announced an agreement to acquire the Florida operations and assets of Green Scientific Labs Holdings Inc., expanding its presence in the legal cannabis and hemp testing market. This transaction will bring ACT Laboratories' operational footprint to eight states by year-end, aiming to standardize testing procedures across its network.ForbesNew Certification Sets Standards For Cannabis Lab TestingSC Labs and ACT Laboratories launched the Trust in Testing certification on Tuesday to standardize cannabis lab testing for purity and potency. The program sets requirements for proficiency testing, quality management, and ethics, and brands can display a seal. The standards may be incorporated into state regulations.Lansing State JournalMichigan's Cannabis Regulatory Agency cites Lansing lab, other marijuana businessesMichigan's Cannabis Regulatory Agency cited 12 licensed companies, including Lansing lab ACT Laboratories, for non-compliance. ACT Laboratories was fined $9,000 for missing annual financial statement deadlines. Other businesses faced penalties for tracking, security, and waste disposal violations.PR NewswireACT Laboratories, Inc. Expands into Massachusetts with the Acquisition of CDX AnalyticsACT Laboratories, Inc. has announced an agreement to acquire CDX Analytics, a cannabis testing laboratory based in Massachusetts, to expand its geographic footprint and scientific capabilities. Upon completion of the deal, which is subject to regulatory approval, ACT Labs will operate in six states including Illinois, Michigan, New York, Ohio, and Pennsylvania, with plans to enter a seventh state by early 2023.BioSpaceACT Laboratories, Inc. Expands into Massachusetts with the Acquisition of CDX AnalyticsACT Laboratories, Inc. has entered into an agreement to acquire CDX Analytics, LLC, a cannabis testing laboratory based in Massachusetts, to expand its geographic footprint and scientific capabilities. This acquisition brings ACT Labs' operational presence to six states, with plans to potentially reach seven by early 2023, subject to regulatory approval in Massachusetts. The deal aims to consolidate leadership in the legal cannabis market by leveraging standardized best practices and advanced testing technologies.New Cannabis VenturesThis $100 Million Cannabis Fund Invests in Companies Addressing Pain Points in the Supply Chain – NCV MediaIntrinsic Capital Partners launched a $102 million equity fund focused on investing in cannabis industry companies that address supply chain pain points. The firm has deployed approximately $65 million so far into portfolio companies including Act Laboratories, Treez, Hound Labs, and Elemental Brands. The investment strategy targets high-margin, scalable businesses with strong management teams and potential for long-term growth.MjbizdailyNew $102 million equity fund targets ancillary cannabis businessesIntrinsic Capital Partners raised $102 million in an equity fund targeting legal marijuana and hemp businesses. It committed $65 million to four companies, including ACT Laboratories, Treez, Hound Labs, and Elemental Brand, and plans to invest in two or three additional firms.